48 year old Female with Metastatic Breast Cancer M.K. presented 12/96 for treatment of breast adenocarcinoma, poorly differentiated. Her original diagnosis was made in 1990 when she had a lumpectomy. An evaluation of hip pain in 1996 showed bilateral breast masses, positive bilateral axillary lymph nodes, and metastases of the sternum, ilia and sacrum. After a bilateral masectomy, an aggressive alternative medical therapy was begun (all standard treatments were refused). After various alternative protocols, the patient stabilized regarding metastases, pain control, and immune function, although she reported that she was not feeling well.
M.K. had AHCC added to her treatment protocol 2/99 - 6 gms per day in divided doses. After 10 weeks on AHCC she showed a significant improvement in reported well-being as well as improved immunological parameters. These improved results (measured 4/16/99 compared with 1/28/99) included: (a) Total WBC 3.6 vs. 2.8 Th/mm3; (b) Helper-Inducer T-cells (CD4) 275 vs. 232; (c) Total lymphocytes 810 vs. 742; (d) Total T lymphocytes 492 vs. 460; (e) B lymphocytes 124 vs. 68; and (f) Helper/Suppressor ration 1.3 vs. 1.1.
M.K. had AHCC added to her treatment protocol 2/99 - 6 gms per day in divided doses. After 10 weeks on AHCC she showed a significant improvement in reported well-being as well as improved immunological parameters. These improved results (measured 4/16/99 compared with 1/28/99) included: (a) Total WBC 3.6 vs. 2.8 Th/mm3; (b) Helper-Inducer T-cells (CD4) 275 vs. 232; (c) Total lymphocytes 810 vs. 742; (d) Total T lymphocytes 492 vs. 460; (e) B lymphocytes 124 vs. 68; and (f) Helper/Suppressor ration 1.3 vs. 1.1.
- Joel S. Edman, D.Sc. and Dr. Fred Pescatore, M.D.
